AspenBio Pharma (APPY) Announces Quarterly Earnings Results, Beats Estimates By $0.01 EPS
AspenBio Pharma (NASDAQ:APPY) released its earnings data on Tuesday. The company reported ($0.14) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.01, American Banking News.com reports.
Shares of AspenBio Pharma (NASDAQ:APPY) opened at 1.96 on Tuesday. AspenBio Pharma has a one year low of $1.15 and a one year high of $3.88. The stock has a 50-day moving average of $2.13 and a 200-day moving average of $2.2. The company’s market cap is $60.7 million.
AspenBio Pharma, Inc (NASDAQ:APPY) is a bio-pharmaceutical company dedicated to the discovery, development, manufacture, and marketing of products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.